Exelixis Looks To Early-Stage Option Rights As Low-Risk Pipeline Expansion Play

 
• By Joseph Haas
  
Busy pace
Exelixis is maintaining a busy pace with Cabometyx and two new deals • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business